A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

NCT05027204 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Docetaxel
DRUG: Nivolumab

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.